British Medical Journal

View more issues:

Articles in Oct 31, 1998 issue of British Medical Journal

• Single dose of anti-D immunoglobulin for antenatal prophylaxis is smaller in the Netherlands than in the United Kingdom
  by Bob van Dijk
• Iceland breast cancer study questions the risk attributable to gene mutations
  by Vicki Madden
• The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials
  by Regina Kunz
• Use of randomisation in the Medical Research Council's clinical trial of streptomycin in pulmonary tuberculosis in the 1940s
  by Alan Yoshioka
• Ovarian ablation in breast cancer, 1896 to 1998: milestones along hierarchy of evidence from case report to Cochrane review
  by Michael J. Clarke
• Tuberculosis: story of medical failure
  by Chris Holme
• UK surgeons may undergo performance review every five years
  by Susan Mayor
• Nurse shortage threatens UK care
  by Louise McKee
• Endpiece: How to buy gadgets
• Efficient management of randomised controlled trials: nature or nurture
  by Barbara Farrell
• Choosing between randomised and non-randomised studies: a systematic review
  by MJ Campbell
• In brief
• Fifty years ago: The new NHS: The BMA under fire
• Endpiece: Alternative definitions
• Words Nosocomial
• GPs in England will receive advice about PCGs
  by Linda Beecham
• Cholesterol lowering diets and coronary heart disease
  by M F Oliver
• US abortion doctor shot dead
  by James Ciment
• One hundred years ago: Labour and refreshment
• Controlled trials: the 1948 watershed
  by Richard Doll
• The controlled clinical trial turns 100 years: Fibiger's trial of serum treatment of diphtheria
  by Asbjorn Hrobjartsson
• Corrections
• WMA to examine doping in sport
  by Linda Beecham
• Being a modern pharmaceutical company
  by Richard Sykes
• Neutron beam therapy targets brain cancer
  by Zosia Kmietowicz
• Randomised controlled trial of patient centred care of diabetes in general practice: impact on current wellbeing and future disease risk
  by Ann Louise Kinmonth
• "A calculated risk": the Salk polio vaccine field trials of 1954
  by Marcia Meldrum
• Randomised Controlled Trials: A User's Guide
  by John-Paul Vader
• Obituaries
• Randomised controlled trial exists of levonorgestrel intrauterine system for menorrhagia
  by Amaju Ikomi
• BMA warns about cuts to defence medical services
  by Linda Beecham
• A memorable patient:The inflating lady
• Cholestanol and survival with simvastatin
• BOOKCASE
  by Christopher Martyn
• EU doctors get caught in training trap
  by Andrea Periati
• Unbiased, relevant, and reliable assessments in health care
  by Iain Chalmers
• Unmatched bone marrow transplants successfully treat leukaemia
  by Judy Siegel-Itzkovich
• A memorable patient: Never underestimate a placebo
  by J H Baron
• The public has a role to play in translating evidence into practice
  by Giok J. Ong
• Evaluating new treatments
  by Lawrence Cranberg
• Cluster randomised trials: time for improvement
  by Marion K Campbell
• US expands prescribing recommendations for aspirin
  by Deborah Josefson
• A patient to remember: A surfeit of experts
  by H.A. Dewar
• Marketing medicines through randomised controlled trials: the case of interferon
  by Toine Pieters
• Protecting children from armed conflict
• Clarification of comments on trial of aminosidine in visceral leishmaniasis
  by P Olliaro
• Confusion remains over patient packs
  by Linda Beecham
• Clinical trials in primary care
  by Robbie Foy
• UK paediatric surgeon wins libel damages
  by Clare Dyer
• Reporting on quality of life in randomised controlled trials: bibliographic study
  by Caroline Sanders
• Why are researchers surprised when there is not a smooth transition from research into practice?
  by Hilda Bastian
• Winter draws on
  by James Owen Drife
• Attention deficit hyperactivity disorder in children
• Website Of The Week
  by Douglas Carnall
• Trials: the next 50 years
  by Richard Peto
• UK survey shows improved diet in elderly
  by John Warden
• Analysis and interpretation of cost data in randomised controlled trials: review of published studies
  by Julie A Barber
• Minerva
• Expert team to investigate concerns at Scottish hospital
  by Bryan Christie
• Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial
  by Katie Featherstone
• The ethics of randomised controlled trials from the perspectives of patients, the public, and healthcare professionals
  by Sarah J.L. Edwards
• Experimentation and social interventions: a forgotten but important history
  by Ann Oakley
• Urinary Disorders and Male Health: A Decision Making Guide for Patients
  by Trevor Gibbs